- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00630461
Safety Study of 20,000 EU of Clinical Center Reference Endotoxin in Allergic Adults With and Without Mild Asthma
October 5, 2012 updated by: David B. Peden, MD, University of North Carolina, Chapel Hill
Endotoxin is a component of outdoor air pollution, an air contaminant found in a number of different workplaces, and is even found in homes.
The endotoxin used for this study is obtained from the National Institutes of Health, and is called "Clinical Center Reference Endotoxin", or CCRE.
The purpose of this Phase 1 research study is to identify a dose of inhaled endotoxin that is safe (does not cause prolonged cough, shortness of breath or other problems), but causes changes in your sputum cell samples that the scientists can measure.
Phase 1 research studies like this one are not intended to be a treatment, but are a scientific investigation.
Eventually, with these types of studies we will be able to examine why some people are more sensitive to endotoxin.
Scientists at other universities have found that while most people do not have a considerable lung response to endotoxin at doses as high as 60,000 EU (endotoxin units), a few respond to as little as a total dose of 4500 EU.
Our study is designed to identify if using a dose of 20,000 EU causes changes in the lung cells but does not cause symptoms in our study subjects.
In our previous studies in our lab, using an endotoxin from another source, we have used higher doses (15,000 EUs) in subjects with asthma with no major problems, and we have used 10,000 EUs of CCRE in subjects with allergies and asthma without problems.
We have used 20,000 EUs of CCRE in healthy individuals with no major problems.
Study Overview
Status
Terminated
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
4
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- UNC Center for Environmental Medicine, Asthma and Lung Biology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Mild allergic rhinitis
- Mild allergic asthma
- Normal lung function
- No other chronic illness
Exclusion Criteria:
- Use of inhaled or oral steroids
- Emergency treatment of asthma in last year
- Inhaled tobacco use
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Increased sputum neutrophils with no adverse events
Time Frame: 6 hours post challenge
|
6 hours post challenge
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: David b Peden, MD, MS, University of North Carolina
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2008
Primary Completion (Actual)
May 1, 2012
Study Completion (Actual)
May 1, 2012
Study Registration Dates
First Submitted
February 28, 2008
First Submitted That Met QC Criteria
March 6, 2008
First Posted (Estimate)
March 7, 2008
Study Record Updates
Last Update Posted (Estimate)
October 8, 2012
Last Update Submitted That Met QC Criteria
October 5, 2012
Last Verified
October 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Infections
- Respiratory Tract Infections
- Respiratory Tract Diseases
- Immune System Diseases
- Lung Diseases
- Hypersensitivity, Immediate
- Bronchial Diseases
- Otorhinolaryngologic Diseases
- Lung Diseases, Obstructive
- Respiratory Hypersensitivity
- Hypersensitivity
- Nose Diseases
- Asthma
- Rhinitis
- Rhinitis, Allergic
Other Study ID Numbers
- 07-2026 GCRC 2627
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mild Allergic Rhinitis
-
Eurofarma Laboratorios S.A.CompletedMild to Moderate Persistent Allergic RhinitisBrazil
-
GlaxoSmithKlineCompleted
-
Universitaire Ziekenhuizen KU LeuvenAZ Sint-Jan AVRecruitingPerennial Allergic Rhinitis | Seasonal Allergic Rhinitis | Local Allergic RhinitisBelgium
-
University of North Carolina, Chapel HillCompletedAllergic Rhinitis | Mild AsthmaUnited States
-
Organon and CoCompletedPerennial Allergic Rhinitis | Seasonal Allergic Rhinitis
-
Humanis Saglık Anonim SirketiCompletedPerennial Allergic Rhinitis | Seasonal Allergic RhinitisIndia
-
Organon and CoCompletedPerennial Allergic Rhinitis | Seasonal Allergic Rhinitis
-
Organon and CoCompletedPerennial Allergic Rhinitis | Seasonal Allergic Rhinitis
-
ALK-Abelló A/SCompletedPerennial Allergic Rhinitis | Seasonal Allergic Rhinitis
Clinical Trials on Clinical Center Reference Endotoxin
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)CompletedAsthma | Rhinitis, Allergic, Perennial | Rhinitis, Allergic, SeasonalUnited States
-
University of North Carolina, Chapel HillNational Institute of Environmental Health Sciences (NIEHS)CompletedHealthy AdultsUnited States
-
University of North Carolina, Chapel HillNational Institute of Environmental Health Sciences (NIEHS)Terminated
-
University of North Carolina, Chapel HillNational Institute of Allergy and Infectious Diseases (NIAID)CompletedHypersensitivity | AsthmaUnited States
-
John SundyTerminated
-
National Jewish HealthNot yet recruitingAsthma | Asthma; EosinophilicUnited States
-
University of North Carolina, Chapel HillUnited States Department of Defense; RTI International; Environmental Protection...Completed
-
Rigshospitalet, DenmarkBispebjerg HospitalCompletedSystemic Inflammatory Response SyndromeDenmark
-
Robert J Noveck, M.D.Foundation for the National Institutes of HealthCompleted
-
Medical University of ViennaCompletedHealthy Subjects | Imparied Retinal Vascular ReactivityAustria